AMPD1, a plasma cell specific purine metabolic molecule, is a novel therapeutic target for myeloma

Yawara Kawano

Presentation information

Oral Session

Oral Session 2-9C Multiple Myeloma: Basic (Novel Molecular Targets）

Sat. Oct 12, 2019 2:50 PM - 3:50 PM No.9 (Tokyo International Forum, 4F G402)

Chair: Yutaka Hattori (Div. of Clinical Physiology and Therapeutics, Faculty of Pharmacy, Keio University)

[OS2-9C-2] AMPD1, a plasma cell specific purine metabolic molecule, is a novel therapeutic target for myeloma

Yawara Kawano¹, Takayuki Sasano², Yuki Inada², Nao Nishimura¹, Saki Kushima², Hiroyuki Hata², Masao Matsuoka¹ (1.Dept of Hematology, Kumamoto Univ Hospital, Kumamoto, Japan, 2.Faculty of Medical Sciences, Kumamoto University, Kumamoto, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.